Nektar Therapeutics NKTR
NASDAQ NKTR
$46.99 -13.55 (-22.39%)
At close: Oct 1, 2026 · 4:00 PM EDT

Nektar Therapeutics (NKTR) Goodwill impairment charges (2023)

Updated

Nektar Therapeutics (NKTR) reported Goodwill impairment charges of $76.5 million for FY2023.

Analysis

Nektar Therapeutics (NKTR) Goodwill impairment charges (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Nektar Therapeutics 2.00 Bn 232.24 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 76.50 Mn
API Access

Nektar Therapeutics Goodwill impairment charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=goodwill-impairment-charges&ticker=NKTR&period=max&api_key=YOUR_API_KEY